NSTM (NovelStem International) 6-1 Month Momentum %: 14.60% (As of Sep. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is NovelStem International 6-1 Month Momentum %?

NovelStem International NSTM -26.36% 6-1 Month Momentum % is 14.60% as of Sep. 17, 2026. The stock has 3 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, NovelStem International ranks better than 68.37% on this metric.

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2026-09-17), NovelStem International's 6-1 Month Momentum % is 14.60%.

The industry rank for NovelStem International's 6-1 Month Momentum % or its related term are showing as below:

NSTM's 6-1 Month Momentum % is ranked better than
68.37% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.45 vs NSTM: 14.60

NovelStem International  (OTCPK:NSTM) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

NovelStem International 6-1 Month Momentum % Related Terms

NSTM vs NOTVQ, PRPH, FUNI: 6-1 Month Momentum % Comparison

For the Diagnostics & Research subindustry, NovelStem International's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NovelStem International 6-1 Month Momentum % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NovelStem International's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where NovelStem International's 6-1 Month Momentum % falls into.


NovelStem International  (OTCPK:NSTM) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-1 Month Momentum % →
What does a 6-1 Month Momentum % of 14.60% mean?
NovelStem International (NSTM) has a 6-1 Month Momentum % of 14.60% as of Sep. 17, 2026. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on NovelStem International and its competitors. According to the industry distribution chart, NovelStem International ranks #68 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 31.6%.
Is NovelStem International's 6-1 Month Momentum % too high?
NovelStem International's current 6-1 Month Momentum % is 14.60%. Based on the distribution chart, NovelStem International ranks #68 out of 215 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint.
How does NovelStem International's 6-1 Month Momentum % compare to NOTVQ and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, NovelStem International ranks #68 out of 215 companies for 6-1 Month Momentum %. This puts NovelStem International in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-1 Month Momentum % for a Medical Diagnostics & Research company?
A good 6-1 Month Momentum % depends on the Medical Diagnostics & Research industry context. However, 6-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-1 Month Momentum % mean?
A high 6-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on NovelStem International and its competitors. NovelStem International's current 6-1 Month Momentum % is 14.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovelStem International stock overvalued right now?
NovelStem International (NSTM) has a current 6-1 Month Momentum % of 14.60%. The current 6-1 Month Momentum % is 14.60%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-1 Month Momentum % calculated?
6-1 Month Momentum % is calculated from a company's financial statements. For NovelStem International (NSTM), the current 6-1 Month Momentum % is 14.60% as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NovelStem International Business Description

Address 7740 Cavern Lane, Suite 100, Parkland, FL, USA, 33067
NovelStem International Corp is a holding company. Through its subsidiaries, the company is engaged in the development and commercialization of diagnostic technology that can predict patients' anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. The company also has an interest in a book publishing franchise.